BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benito N, Sued O, Moreno A, Pablo Horcajada J, Gonz??lez J, Navasa M, Rimola A. Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area: . Transplantation 2002;74:1381-6. [DOI: 10.1097/00007890-200211270-00006] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Rashid HU, Begum NAS, Kashem TS. Mycobacterial infections in solid organ transplant recipients. Korean J Transplant 2021;35:208-17. [DOI: 10.4285/kjt.21.0033] [Reference Citation Analysis]
2 Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522 [DOI: 10.5500/wjt.v11.i12.512] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
3 Taylor TH, Ibrahim D, Lewis JH. Tuberculosis of the Liver, Biliary Tract, and Pancreas. Tuberculosis and Nontuberculous Mycobacterial Infections 2021. [DOI: 10.1128/9781555817138.ch25] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Abad CL, Razonable RR. Prevention and treatment of tuberculosis in solid organ transplant recipients. Expert Rev Anti Infect Ther 2020;18:63-73. [PMID: 31826668 DOI: 10.1080/14787210.2020.1704255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Leong LY, Lin PC, Chi CY, Chou CH, Lu MC, Liao WC, Ho MW, Wang JH, Jeng LB. Risk factors of tuberculosis after liver transplant in a tertiary care hospital. J Microbiol Immunol Infect 2021;54:312-8. [PMID: 31668794 DOI: 10.1016/j.jmii.2019.08.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Abad CLR, Deziel PJ, Razonable RR. Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review. Transpl Infect Dis 2019;21:e13178. [PMID: 31541575 DOI: 10.1111/tid.13178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
7 Uzorka JW, Wallinga J, Kroft LJM, Ottenhoff THM, Arend SM. Radiological Signs of Latent Tuberculosis on Chest Radiography: A Systematic Review and Meta-Analysis. Open Forum Infect Dis 2019;6:ofz313. [PMID: 31363778 DOI: 10.1093/ofid/ofz313] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
8 Maung Myint T, Rogerson TE, Noble K, Craig JC, Webster AC. Tests for latent tuberculosis in candidates for solid organ transplantation: A systematic review and meta-analysis. Clin Transplant 2019;33:e13643. [PMID: 31225918 DOI: 10.1111/ctr.13643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Shen Y, Ma H, Luo D, Guan J. The T-SPOT.TB assay used for screening and monitoring of latent tuberculosis infection in patients with Behçet’s disease pre- and post-anti-TNF treatment: A retrospective study. Journal of the Chinese Medical Association 2019;82:375-80. [DOI: 10.1097/jcma.0000000000000071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wigg AJ, Narayana SK, Anwar S, Ramachandran J, Muller K, Chen JW, John L, Hissaria P, Kaambwa B, Woodman RJ. High rates of indeterminate interferon‐gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidates. Transpl Infect Dis 2019;21:e13087. [DOI: 10.1111/tid.13087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Ertuğrul G, Düger M. Prophylaxis for latent tuberculosis infection in liver transplant recipients. Journal of Surgery and Medicine 2019. [DOI: 10.28982/josam.527957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Meije Y, Kwak EJ, Aguado JM. Prevention and Treatment of Mycobacterial Infections. Infectious Diseases in Solid-Organ Transplant Recipients 2019. [DOI: 10.1007/978-3-030-15394-6_14] [Reference Citation Analysis]
13 Rahimifard N, Mahmoudi S, Mamishi S, Pourakbari B. Prevalence of latent tuberculosis infection in transplant candidates: A systematic review and meta-analysis. Microb Pathog 2018;125:401-10. [PMID: 30291870 DOI: 10.1016/j.micpath.2018.09.040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hand J, Sigel K, Huprikar S, Hamula C, Rana M. Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON® -TB Gold-based pre-transplant screening performance and active tuberculosis post-transplant. Transpl Infect Dis 2018;20:e12845. [PMID: 29359834 DOI: 10.1111/tid.12845] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
15 Aguado JM, Silva JT, Samanta P, Singh N. Tuberculosis and Transplantation. Microbiol Spectr. 2016;4. [PMID: 27809952 DOI: 10.1128/microbiolspec.tnmi7-0005-2016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
16 McMullan GS, Lewis JH. Tuberculosis of the Liver, Biliary Tract, and Pancreas. Microbiol Spectr 2017;5. [PMID: 28233514 DOI: 10.1128/microbiolspec.TNMI7-0025-2016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
17 Moon HH, Park SY, Kim JM, Park JB, Kwon CHD, Peck KR, Kim SJ, Lee SK, Joh JW. Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area. Ann Transplant. 2017;22:338-345. [PMID: 28579606 DOI: 10.12659/aot.902989] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
18 Aguado JM, Tiago Silva J, Samanta P, Singh N. Tuberculosis and Transplantation. Tuberculosis and Nontuberculous Mycobacterial Infections 2017. [DOI: 10.1128/9781555819866.ch36] [Reference Citation Analysis]
19 Mcmullan GS, Lewis JH. Tuberculosis of the Liver, Biliary Tract, and Pancreas. Tuberculosis and Nontuberculous Mycobacterial Infections 2017. [DOI: 10.1128/9781555819866.ch27] [Reference Citation Analysis]
20 Machado CM. Transplant Infections in Developing Countries. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Meije Y, Piersimoni C, Torre-Cisneros J, Dilektasli AG, Aguado JM; ESCMID Study Group of Infection in Compromised Hosts. Mycobacterial infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20 Suppl 7:89-101. [PMID: 24707957 DOI: 10.1111/1469-0691.12641] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 9.0] [Reference Citation Analysis]
22 Benito N, García-Vázquez E, Horcajada JP, González J, Oppenheimer F, Cofán F, Ricart MJ, Rimola A, Navasa M, Rovira M, Roig E, Pérez-Villa F, Cervera C, Moreno A. Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study. Clin Microbiol Infect 2015;21:651-8. [PMID: 25882369 DOI: 10.1016/j.cmi.2015.03.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
23 Torre-Cisneros J, San-Juan R, Rosso-Fernández CM, Silva JT, Muñoz-Sanz A, Muñoz P, Miguez E, Martín-Dávila P, López-Ruz MA, Vidal E, Cordero E, Montejo M, Blanes M, Fariñas MC, Herrero JI, Rodrigo J, Aguado JM. Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial. Clin Infect Dis 2015;60:1642-9. [PMID: 25722196 DOI: 10.1093/cid/civ156] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
24 Sidhu A, Verma G, Humar A, Kumar D. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period. Transplantation. 2014;98:671-675. [PMID: 24825525 DOI: 10.1097/tp.0000000000000133] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
25 Olithselvan A, Rajagopala S, Vij M, Shanmugam V, Shanmugam N, Rela M. Tuberculosis in liver transplant recipients: experience of a South Indian liver transplant center. Liver Transpl 2014;20:960-6. [PMID: 24789170 DOI: 10.1002/lt.23903] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
26 Liu J, Yan J, Wan Q, Ye Q, Huang Y. The risk factors for tuberculosis in liver or kidney transplant recipients. BMC Infect Dis 2014;14:387. [PMID: 25015108 DOI: 10.1186/1471-2334-14-387] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
27 de Castilla DL, Rakita RM, Spitters CE, Narita M, Jain R, Limaye AP. Short-course isoniazid plus rifapentine directly observed therapy for latent tuberculosis in solid-organ transplant candidates. Transplantation. 2014;97:206-211. [PMID: 24142036 DOI: 10.1097/tp.0b013e3182a94a2f] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
28 de Lemos AS, Vieira MA, Halpern M, Quaresma RG, Borchardt AC, Santos MA, Gonçalves RT, Santoro-Lopes G. Results of implementation of preventive recommendations for tuberculosis after renal transplantation in an endemic area. Am J Transplant 2013;13:3230-5. [PMID: 24119248 DOI: 10.1111/ajt.12470] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
29 Horne DJ, Narita M, Spitters CL, Parimi S, Dodson S, Limaye AP. Challenging issues in tuberculosis in solid organ transplantation. Clin Infect Dis. 2013;57:1473-1482. [PMID: 23899676 DOI: 10.1093/cid/cit488] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
30 Subramanian AK, Morris MI; AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplant 2013;13 Suppl 4:68-76. [PMID: 23465000 DOI: 10.1111/ajt.12100] [Cited by in Crossref: 129] [Cited by in F6Publishing: 133] [Article Influence: 12.9] [Reference Citation Analysis]
31 Stucchi R, Boin I, Angerami R, Zanaga L, Ataide E, Udo E. Is Isoniazid Safe for Liver Transplant Candidates With Latent Tuberculosis? Transplantation Proceedings 2012;44:2406-10. [DOI: 10.1016/j.transproceed.2012.07.035] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
32 Doblas A, Alcaide F, Benito N, Gurguí M, Torre-Cisneros J. Tuberculosis in solid organ transplant patients. Enferm Infecc Microbiol Clin. 2012;30 Suppl 2:34-39. [PMID: 22542033 DOI: 10.1016/s0213-005x(12)70080-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
33 Dhiman RK, Saraswat VA, Rajekar H, Reddy C, Chawla YK. A guide to the management of tuberculosis in patients with chronic liver disease. J Clin Exp Hepatol 2012;2:260-70. [PMID: 25755442 DOI: 10.1016/j.jceh.2012.07.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
34 Kim SY, Jung GS, Kim SK, Chang J, Kim MS, Kim YS, Kang YA, Joo DJ. Comparison of the tuberculin skin test and interferon-γ release assay for the diagnosis of latent tuberculosis infection before kidney transplantation. Infection 2013;41:103-10. [DOI: 10.1007/s15010-012-0291-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
35 Mansour AE, Abdel-salam M, Besheer TA, Al-arman M. Utility of QuantiFERON-TB Gold In-Tube testing in the detection of latent tuberculosis in liver transplant candidates: . Egyptian Liver Journal 2012;2:67-71. [DOI: 10.1097/01.elx.0000415483.39762.99] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
36 Muñoz P, Fernández NS, Fariñas MC. Epidemiology and risk factors of infections after solid organ transplantation. Enfermedades Infecciosas y Microbiología Clínica 2012;30:10-8. [DOI: 10.1016/s0213-005x(12)70077-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
37 Moreno A, Cervera C, Fortún J, Blanes M, Montejo E, Abradelo M, Len O, Rafecas A, Martín-Davila P, Torre-Cisneros J, Salcedo M, Cordero E, Lozano R, Pérez I, Rimola A, Miró JM; OLT-HIV FIPSE Cohort Investigators. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study. Liver Transpl 2012;18:70-81. [PMID: 21898772 DOI: 10.1002/lt.22431] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
38 Toyokawa N, Kokubu T, Fujioka H. MYCOBACTERIAL TUBERCULOUS TENOSYNOVITIS OF THE EXTENSOR TENDON OCCURRING AFTER LIVER TRANSPLANTATION: A CASE REPORT. Hand Surg 2011;13:37-40. [DOI: 10.1142/s0218810408003797] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
39 Imai S, Ito Y, Hirai T, Imai H, Ito I, Maekawa K, Chin K, Ichiyama S, Uemoto S, Mishima M. Clinical features and risk factors of tuberculosis in living-donor liver transplant recipients. Transplant Infectious Disease 2012;14:9-16. [DOI: 10.1111/j.1399-3062.2011.00680.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
40 Theodoropoulos N, Lanternier F, Rassiwala J, Mcnatt G, Preczewski L, Demayo E, Stosor V, Ison M. Use of the QuantiFERON-TB Gold interferon-gamma release assay for screening transplant candidates: a single-center retrospective study: QuantiFERON-TB Gold candidate screening. Transplant Infectious Disease 2012;14:1-8. [DOI: 10.1111/j.1399-3062.2011.00666.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
41 Rajagopala S, Olithselvan A, Varghese J, Shanmugam N, Rela M. Latent Mycobacterium tuberculosis Infection in Liver Transplant Recipients-Controversies in Current Diagnosis and Management. J Clin Exp Hepatol 2011;1:34-7. [PMID: 25755308 DOI: 10.1016/S0973-6883(11)60120-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Jafri SM, Singal AG, Kaul D, Fontana RJ. Detection and management of latent tuberculosis in liver transplant patients. Liver Transpl 2011;17:306-14. [PMID: 21384513 DOI: 10.1002/lt.22203] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
43 Agoglia L, Balbi E, Halpern M, Roma J, Carius L, Martinho J, Moreira L. Tuberculosis in Liver Transplant Recipients: Prophylaxis in an Endemic Area. Transplantation Proceedings 2011;43:199-202. [DOI: 10.1016/j.transproceed.2010.12.033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
44 Martinez-pellus A, Cortés Puch I. ICU Patients Following Transplantation. Infection Control in the Intensive Care Unit 2011. [DOI: 10.1007/978-88-470-1601-9_19] [Reference Citation Analysis]
45 Rimola A, Navasa M. Liver Transplantation: Prevention and Treatment of Infection. Evidence‐Based Gastroenterology and Hepatology 2010. [DOI: 10.1002/9781444314403.ch43] [Reference Citation Analysis]
46 Subramanian A, Dorman S; AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009;9 Suppl 4:S57-62. [PMID: 20070696 DOI: 10.1111/j.1600-6143.2009.02894.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 6.2] [Reference Citation Analysis]
47 Aguado JM, Torre-cisneros J, Fortún J, Benito N, Meije Y, Doblas A, Muñoz P. Documento de consenso para el tratamiento de la tuberculosis en pacientes con trasplante de órgano sólido. Enfermedades Infecciosas y Microbiología Clínica 2009;27:465-73. [DOI: 10.1016/j.eimc.2008.10.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
48 Holty JE, Gould MK, Meinke L, Keeffe EB, Ruoss SJ. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl 2009;15:894-906. [PMID: 19642133 DOI: 10.1002/lt.21709] [Cited by in Crossref: 99] [Cited by in F6Publishing: 94] [Article Influence: 7.1] [Reference Citation Analysis]
49 Clemente WT, Faria LC, Lima SSS, Vilela EG, Lima AS, Velloso LF, Sanches MD, Cançado OL. Tuberculosis in Liver Transplant Recipients: A Single Brazilian Center Experience. Transplantation 2009;87:397-401. [DOI: 10.1097/tp.0b013e31819289d0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
50 Lindemann M, Dioury Y, Beckebaum S, Cicinnati VR, Gerken G, Broelsch CE, Wrighton-smith P, Grosse-wilde H. Diagnosis of tuberculosis infection in patients awaiting liver transplantation. Human Immunology 2009;70:24-8. [DOI: 10.1016/j.humimm.2008.10.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
51 Zhang X, Lv Y, Xue W, Wang B, Liu C, Tian P, Yu L, Chen X, Liu X. Mycobacterium tuberculosis Infection in Solid Organ Transplant Recipients: Experience From a Single Center in China. Transplantation Proceedings 2008;40:1382-5. [DOI: 10.1016/j.transproceed.2008.01.075] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
52 Grasso A, De Leo P, Malfatti F, Toscanini F, Anselmo M, Menardo G. Late Occurrence of Pleural and Peritoneal Effusion Due to Mycobacterium tuberculosis Infection (TB) in a Patient With Posttransplantation Recurrent HCV Chronic Hepatitis: Safety of Peginterferon and Ribavirin Treatment After Recovery of TB:— A Case Report. Transplantation Proceedings 2008;40:1783-5. [DOI: 10.1016/j.transproceed.2008.02.077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
53 Gómez Mateos J, Aguilar Guisado M, Torre-Cisneros J. [A 21-year old male, with a liver transplantation, with short-duration fever, mediastinic lymph nodes and pulmonary infiltrates]. Med Clin (Barc) 2008;130:267-76. [PMID: 18355429 DOI: 10.1157/13116553] [Reference Citation Analysis]
54 Aguilera V, Berenguer J. Evaluación pretrasplante. Trasplante hepático 2008. [DOI: 10.1016/b978-84-8086-310-0.50002-6] [Reference Citation Analysis]
55 Lumbreras C, García-reyne A, Aguado J. Complicaciones infecciosas. Trasplante hepático 2008. [DOI: 10.1016/b978-84-8086-310-0.50026-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Manuel O, Humar A, Preiksaitis J, Doucette K, Shokoples S, Peleg AY, Cobos I, Kumar D. Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007;7:2797-801. [PMID: 17941955 DOI: 10.1111/j.1600-6143.2007.02011.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 88] [Article Influence: 5.4] [Reference Citation Analysis]
57 Escalante P. Mycobacterial infections in solid organ transplantation: . Current Opinion in Organ Transplantation 2007;12:585-90. [DOI: 10.1097/mot.0b013e3282f13a88] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
58 Wagstaff AJ, Zellweger JP. T-SPOT.TB: an in vitro diagnostic assay measuring T-cell reaction to Mycobacterium tuberculosis-specific antigens. Mol Diagn Ther 2006;10:57-63; discussion 64-5. [PMID: 16646578 DOI: 10.1007/BF03256443] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
59 María Aguado J, García-reyne A, Lumbreras C. Infecciones en los pacientes trasplantados de hígado. Enfermedades Infecciosas y Microbiología Clínica 2007;25:401-10. [DOI: 10.1016/s0213-005x(07)74314-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
60 Jahng AW, Tran T, Bui L, Joyner JL. Safety of Treatment of Latent Tuberculosis Infection in Compensated Cirrhotic Patients During Transplant Candidacy Period. Transplantation 2007;83:1557-62. [DOI: 10.1097/01.tp.0000266578.45634.4f] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
61 Epstein D, Watermeyer G, Kirsch R. Review article: the diagnosis and management of Crohn's disease in populations with high-risk rates for tuberculosis. Aliment Pharmacol Ther 2007;25:1373-88. [PMID: 17539977 DOI: 10.1111/j.1365-2036.2007.03332.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 5.4] [Reference Citation Analysis]
62 Nagai S, Fujimoto Y, Taira K, Egawa H, Takada Y, Kiuchi T, Tanaka K. Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis. Clin Transplant 2007;21:229-34. [DOI: 10.1111/j.1399-0012.2006.00630.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
63 Kwok S, Park S. Guidelines for Prevention of Tuberculosis in Patients with Rheumatoid Arthritis Treated with TNF-alpha Blockers. J Korean Rheum Assoc 2007;14:105. [DOI: 10.4078/jkra.2007.14.2.105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
64 Prieto M, Aguilera V, Berenguer M, Pina R, Benlloch S. Selección de candidatos para trasplante hepático. Gastroenterología y Hepatología 2007;30:42-53. [DOI: 10.1157/13097451] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
65 Forget EJ, Menzies D. Adverse reactions to first-line antituberculosis drugs. Expert Opin Drug Saf. 2006;5:231-249. [PMID: 16503745 DOI: 10.1517/14740338.5.2.231] [Cited by in Crossref: 159] [Cited by in F6Publishing: 202] [Article Influence: 9.4] [Reference Citation Analysis]
66 Jung H, Oh Y, Lee SD, Kim WS, Kim DS, Kim WD, Kim J, Lee SG, Shim TS. Clinical Characteristics of Tuberculosis in Liver or Heart Transplant Recipients. Tuberc Respir Dis 2006;61:440. [DOI: 10.4046/trd.2006.61.5.440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
67 Powell DA, Hunt WG. Tuberculosis in Children: An Update. Advances in Pediatrics 2006;53:279-322. [DOI: 10.1016/j.yapd.2006.04.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
68 Akamatsu N, Sugawara Y, Nakajima J, Kishi Y, Niiya T, Kaneko J, Makuuchi M. Resection of a Pulmonary Lesion After Liver Transplantation: Report of a Case. Surg Today 2005;35:976-8. [DOI: 10.1007/s00595-005-3041-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
69 Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis Infection in Recipients of Solid Organ Transplants. Clinical Infectious Diseases 2005;40:581-7. [DOI: 10.1086/427692] [Cited by in Crossref: 245] [Cited by in F6Publishing: 258] [Article Influence: 13.6] [Reference Citation Analysis]